H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer

Journal of the National Cancer Institute

Volumn 96, Issue 16, 2004, Pages 1248-1254

  Lindmark, Fredrik ^a   Zheng, S Lilly ^d   Wiklund, Fredrik ^a   Bensen, Jeannette ^d   Bälter, Katarina Augustsson ^b   Chang, Baoli ^d   Hedelin, Maria ^b   Clark, Jonathan ^d   Stattin, Pär ^c   Meyers, Deborah A ^d   Adami, Hans Olov ^b   Isaacs, William ^e   Grönberg, Henrik ^a   Xu, Jianfeng ^d  

^a UMEÅ UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; HISTIDINE; MACROPHAGE INHIBITORY CYTOKINE 1 PROTEIN; TRANSFORMING GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; CYTOKINE; DNA; PLAB PROTEIN;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; EXON; FAMILIAL CANCER; GENE CONSTRUCT; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN; DNA SEQUENCE; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PROSTATE TUMOR; RISK;

ADULT; AGED; CASE-CONTROL STUDIES; CYTOKINES; DNA, NEOPLASM; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; SEQUENCE ANALYSIS, DNA; SWEDEN;

EID: 4344570236     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djh227     Document Type: Article

References (26)

1. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7.
2. Askling J, Dickman PW, Karlen P, Brostrom O, Lapidus A, Lofberg R, et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology 2001;120:1356-62.
3. Shacter E, Weitzman SA. Chronic inflammation and cancer. Oncology (Huntingt) 2002;16:217-26.
4. De Marzo AM, Marchi VL, Epstein JI, Nelson WG. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol 1999;155:1985-92.
5. McCarron SL, Edwards S, Evans PR, Gibbs R, Dearnaley DP, Dowe A, et al. Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res 2002;62:3369-72.
6. Carpten J, Nupponen N, Isaacs S, Sood R, Robbins C, Xu J, et al. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet 2002;30:181-4.
7. Xu J, Zheng SL, Komiya A, Mychaleckyj JC, Isaacs SD, Hu JJ, et al. Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Nat Genet 2002; 32:321-5.
8. Bottner M, Suter-Crazzolara C, Schober A, Unsicker K. Expression of a novel member of the TGF-beta superfamily, growth/differentiation factor-15/macrophage-inhibiting cytokine-1 (GDF-15/MIC-1) in adult rat tissues. Cell Tissue Res 1999;297:103-10.
9. Hromas R, Hufford M, Sutton J, Xu D, Li Y, Lu L. PLAB, a novel placental bone morphogenetic protein. Biochim Biophys Acta 1997;1354: 40-4.
10. Thomas R, True LD, Lange PH, Vessella RL. Placental bone morphogenetic protein (PLAB) gene expression in normal, pre-malignant and malignant human prostate: relation to tumor development and progression. Int J Cancer 2001;93:47-52.
11. Paralkar VM, Vail AL, Grasser WA, Brown TA, Xu H, Vukicevic S, et al. Cloning and characterization of a novel member of the transforming growth factor-beta/bone morphogenetic protein family. J Biol Chem 1998;273: 13760-7.
12. Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY, et al. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci U S A 1997; 94:11514-9.
13. Fairlie WD, Russell PK, Wu WM, Moore AG, Zhang HP, Brown PK, et al. Epitope mapping of the transforming growth factor-beta superfarnily protein, macrophage inhibitory cytokine-1 (MIC-1): identification of at least five distinct epitope specificities. Biochemistry 2001;40:65-73.
14. Buckhaults P, Rago C, St. Croix B, Romans KE, Saha S, Zhang L, et al. Secreted and cell surface genes expressed in benign and malignant colorectal tumors. Cancer Res 2001;61:6996-7001.
15. Nakamura T, Scorilas A, Stephan C, Yousef GM, Kristiansen G, Jung K, et al. Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues. Br J Cancer 2003;88:1101-4.
16. Liu T, Bauskin AR, Zaunders J, Brown DA, Pankurst S, Russell PJ, et al. Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells. Cancer Res 2003;63:5034-40.
17. Welsh JB, Sapinoso LM, Kern SG, Brown DA, Liu T, Bauskin AR, et al. Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. Proc Natl Acad Sci U S A 2003;100:3410-5.
18. Hsieh CL, Oakley-Girvan I, Balise RR, Halpern J, Gallagher RP, Wu AH, et al. A genome screen of families with multiple cases of prostate cancer: evidence of genetic heterogeneity. Am J Hum Genet 2001;69:148-58.
19. Wiklund F, Gillanders E, Bergh A, Damber JE, Emanuelsson M, Goransson I, et al. The Prostate 2003;57:290-7.
20. Weir BS. Genetic data analysis II. Sunderland (MA): Sinauer; 1996.
21. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002;70:425-34.
22. Gong G, Oakley-Girvan I, Wu AH, Kolonel LN, John EM, West DW, et al. Segregation analysis of prostate cancer in 1,719 white, African-American and Asian-American families in the United States and Canada. Cancer Causes Control 2002;13:471-82.
23. Schaedel C, Hjelte L, de Monestrol I, Johannesson M, Kollberg H, Kornfalt R, et al. Three common CFTR mutations should be included in a neonatal screening programme for cystic fibrosis in Sweden. Clin Genet 1999;56: 318-22.
24. Heim RA, Sugarman EA, Allitto BA. Improved detection of cystic fibrosis mutations in the heterogeneous U.S. population using an expanded, panethnic mutation panel. Genet Med 2001;3:168-76.
25. Stattin P, Johansson R, Damber JE, Helstrom M, Hugosson J, Lundgren R, et al. Scand J Urol Nephrol 2003;37:461-5.
26. Sarma AV, Schottenfeld D. Prostate cancer incidence, mortality, and survival trends in the United States, 1981-2001. Semin Urol Oncol 2002;20:3-9.